CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR GPRC5D AND BCMA Application WO-2024031091-A3 World Intellectual Property Organisation (WIPO) 14 Mar 2024
Compositions and methods for treating cancer with TSLPR-CD19 or TSLPR-CD22 immunotherapy Grant US-11497770-B2 United States of America 15 Nov 2022
COMPOSITIONS AND METHODS FOR TREATING CANCER WITH TSLPR-CD19 OR TSLPR-CD22 IMMUNOTHERAPY Application WO-2021262723-A1 World Intellectual Property Organisation (WIPO) 30 Dec 2021